专家对口腔潜在恶性疾病的5氨基烯酸光动力疗法达成共识
The Chinese journal of dental research
|January 7, 2026
概括
使用5-aminolevulinic酸 (5-ALA-PDT) 的光动力疗法为口腔潜在恶性疾病 (OPMDs) 提供了非侵入性治疗. 本指南规范了5-ALA-PDT协议,以改善患者的治疗结果和临床有效性.
科学领域:
- 口腔医学是指口腔医学.
- 在瘤学瘤学.
- 摄影化学的使用.
背景情况:
- 口腔潜在恶性疾病 (OPMDs) 需要有效的,非侵入性的治疗选择.
- 使用5-氨基氨基酸 (5-ALA) 的光动力学疗法 (PDT) 对OPMDs有希望.
- 需要标准化的协议来优化5-ALA-PDT的疗效和安全性.
研究的目的:
- 提供一个全面的共识指南,5-ALA-PDT在管理OPMDs的临床应用.
- 标准化治疗方案,包括辐射参数和损伤评估.
- 提高临床结果,并为口腔粘膜疾病中的5-ALA-PDT建立科学基础.
主要方法:
- 基于当前的临床证据和专家意见,制定共识文件.
- 详细的建议,包括患者选择,诊断和治疗方案.
- 治疗后有效性评估和不良事件管理指南.
主要成果:
- 5-ALA-PDT是一种重要的非侵入性治疗方法,用于治疗口腔白血病和红血病等OPMD.
- 该共识提供了关于辐射剂量,时间,光源和治疗前准备的详细建议.
- 标准化程序旨在改善临床结果,并应对管理口腔粘膜疾病的挑战.
结论:
- 5-ALA-PDT代表了对OPMDs的一个有价值的治疗策略.
- 通过这种共识,对5-ALA-PDT的标准化将提高治疗的一致性和有效性.
- 本指南支持口腔粘膜专家优化口腔粘膜疾病PDT.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...